Quest Diagnostics Reports First Quarter 2023 Financial Results; Updates Guidance for Full Year 2023

First quarter revenues of $2.33 billion, down 10.7% from 2022 First quarter reported diluted earnings per share (“EPS”) of $1.78, down 39.0% from 2022; and adjusted diluted EPS of $2.04, down 36.6% from 2022 First quarter base business revenues of $2.21 billion, up 10.0% from 2022 Full…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.